Vagus Nerve Stimulation (VNS)
Sponsors
Cyberonics, Inc., MicroTransponder Inc., University Hospital, Grenoble, LivaNova, University of Pittsburgh
Conditions
ArrhythmiaCongestive Heart FailureCrohn's DiseaseMajor Depressive DisorderSevere TinnitusStrokeTreatment Resistant DepressionTreatment Resistant Depression (TRD)
Phase 1
Phase 3
Unknown Phase
Pivotal Trial (D02) of Vagus Nerve Stimulation (VNS) for Treatment-Resistant Depression (TRD)
CompletedNCT00533832
Start: 2000-07-31End: 2005-07-31Updated: 2007-09-24
Proof-of-Concept Study Assessing VNS Paired With Tones for Tinnitus
CompletedNCT01253616
Start: 2010-12-31End: 2012-06-30Updated: 2017-02-17
VNS During Rehabilitation for Improved Upper Limb Motor Function After Stroke
CompletedNCT02243020
Start: 2014-10-31End: 2022-06-01Updated: 2022-09-15
Autonomic Regulation Therapy in Heart Failure With Preserved Ejection Fraction
CompletedNCT03163030
Start: 2014-08-31End: 2021-12-31Updated: 2023-05-06
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression
RecruitingNCT03887715
Start: 2019-09-26End: 2030-12-31Target: 6800Updated: 2026-06-15
VNS-induced Corticospinal Plasticity
CompletedNCT04088565
Start: 2019-09-22End: 2021-11-09Updated: 2022-11-01
A Study to Evaluate the Effect of Vagus Nerve Stimulation in Patients Undergoing VT Ablation
CompletedNCT04359004
Start: 2020-12-08End: 2023-10-30Updated: 2023-11-13
Treatment Resistant Depression and Vagus Nerve Stimulation
RecruitingNCT05952674
Start: 2024-02-19End: 2033-02-19Target: 166Updated: 2026-06-23